secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-07-02T23:59:59+00:00
Accession:  0001193125-25-154170
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose defers interest payment on Hanmi loan to December 31, 2025
-----------------------------------------------------------------

- Interest for Dec 21, 2024–Mar 31, 2025, originally due June 27, 2025, deferred to Dec 31, 2025.
- Interest for Mar 31–Jun 30, 2025 also deferred to Dec 31, 2025.
- Interest Deferral Agreement signed June 24, 2025 between Aptose and Hanmi.
- Aptose is a clinical-stage precision oncology company developing tuspetinib for AML.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000119312525154170/0001193125-25-154170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000119312525154170/d68389d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-154170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer